Using a household-structured branching process to analyse contact tracing in the SARS-CoV-2 pandemic.
COVID-19
SARS-CoV-2
contact tracing
epidemic
epidemiology
infectious disease
Journal
Philosophical transactions of the Royal Society of London. Series B, Biological sciences
ISSN: 1471-2970
Titre abrégé: Philos Trans R Soc Lond B Biol Sci
Pays: England
ID NLM: 7503623
Informations de publication
Date de publication:
19 07 2021
19 07 2021
Historique:
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
11
6
2021
Statut:
ppublish
Résumé
We explore strategies of contact tracing, case isolation and quarantine of exposed contacts to control the SARS-CoV-2 epidemic using a branching process model with household structure. This structure reflects higher transmission risks among household members than among non-household members. We explore strategic implementation choices that make use of household structure, and investigate strategies including two-step tracing, backwards tracing, smartphone tracing and tracing upon symptom report rather than test results. The primary model outcome is the effect of contact tracing, in combination with different levels of physical distancing, on the growth rate of the epidemic. Furthermore, we investigate epidemic extinction times to indicate the time period over which interventions must be sustained. We consider effects of non-uptake of isolation/quarantine, non-adherence, and declining recall of contacts over time. Our results find that, compared to self-isolation of cases without contact tracing, a contact tracing strategy designed to take advantage of household structure allows for some relaxation of physical distancing measures but cannot completely control the epidemic absent of other measures. Even assuming no imported cases and sustainment of moderate physical distancing, testing and tracing efforts, the time to bring the epidemic to extinction could be in the order of months to years. This article is part of the theme issue 'Modelling that shaped the early COVID-19 pandemic response in the UK'.
Identifiants
pubmed: 34053253
doi: 10.1098/rstb.2020.0267
pmc: PMC8165594
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20200267Subventions
Organisme : Wellcome Trust
ID : 209075/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V038613/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202562/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : MR/V004832/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V004832/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V028618/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S020462/1
Pays : United Kingdom
Références
PLoS Comput Biol. 2010 Mar 26;6(3):e1000721
pubmed: 20361048
Wellcome Open Res. 2020 Apr 9;5:67
pubmed: 32685698
Lancet Public Health. 2020 Aug;5(8):e452-e459
pubmed: 32682487
Math Biosci. 2012 Jan;235(1):85-97
pubmed: 22085761
Lancet Digit Health. 2020 Dec;2(12):e658-e666
pubmed: 33078140
BMJ Glob Health. 2020 Jun;5(6):
pubmed: 32540965
Lancet Infect Dis. 2020 Oct;20(10):1141-1150
pubmed: 32562601
Lancet Infect Dis. 2020 Sep;20(9):1025-1033
pubmed: 32445710
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
BMC Infect Dis. 2021 Jul 22;21(1):700
pubmed: 34294037
Euro Surveill. 2020 Apr;25(17):
pubmed: 32372755
Nat Phys. 2021 May;17:652-658
pubmed: 34367312
Lancet Public Health. 2021 Jan;6(1):e30-e38
pubmed: 33308423
Infect Dis Model. 2020 Jul 04;5:409-441
pubmed: 32691015
Clin Infect Dis. 2020 Nov 5;71(8):1943-1946
pubmed: 32301964
J R Soc Interface. 2008 Jul 6;5(24):791-9
pubmed: 18055417
J Infect. 2020 Jul;81(1):179-182
pubmed: 32283139
Clin Infect Dis. 2021 May 4;72(9):e334-e342
pubmed: 32738143
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120137
pubmed: 23798686
BMC Med. 2020 May 7;18(1):124
pubmed: 32375776
Lancet Public Health. 2020 May;5(5):e279-e288
pubmed: 32311320
Science. 2020 May 8;368(6491):
pubmed: 32234805
Elife. 2020 Aug 24;9:
pubmed: 32831176
Nat Med. 2020 Oct;26(10):1616-1622
pubmed: 32770169
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Nat Commun. 2021 Jan 11;12(1):232
pubmed: 33431829
Nature. 2021 Feb;590(7844):134-139
pubmed: 33348340
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6146-51
pubmed: 15071187
Public Health. 2020 May;182:163-169
pubmed: 32334182
Wellcome Open Res. 2020 Oct 13;5:239
pubmed: 33154980
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200270
pubmed: 34053257
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):4023-4028
pubmed: 28351976
Emerg Infect Dis. 2020 Jun;26(6):1341-1343
pubmed: 32191173
BMJ. 2021 Mar 31;372:n608
pubmed: 33789843
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
Epidemiol Infect. 2009 May;137(5):654-61
pubmed: 18840319
Lancet. 2003 May 24;361(9371):1761-6
pubmed: 12781533
Int J Tuberc Lung Dis. 2014 Jun;18(6):640-6
pubmed: 24903932
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Wellcome Open Res. 2020 Apr 1;5:58
pubmed: 32685697
PLoS One. 2006 Dec 20;1:e12
pubmed: 17183638
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404
PLoS Med. 2008 Mar 25;5(3):e74
pubmed: 18366252
Public Health. 2020 Oct;187:41-52
pubmed: 32898760
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930